Literature DB >> 15067637

Ultralok uncemented femoral prostheses: 12 to 15 year follow-up evaluation.

Peter Grant1, Bjarne Grøgaard, Lars Nordsletten.   

Abstract

The results of total hip arthroplasty (THA) in young patients with osteoarthritis have been discouraging. In this prospective study, 78 patients (89 THA) were consecutively included and followed for 12 to 15 years (mean, 12.2 years) after the index surgery with the uncemented Ultralok femoral prosthesis (Zimmer, Wiltshire, UK). Age at surgery was 59.8 years (40 to 76). The follow-up process included an in-office clinical evaluation and a radiographic evaluation. A cumulative survival of 96.6% (with the end point defined as revision of the femoral component because of mechanical or radiographic loosening) was found for the femoral component after13 years, and all unrevised components were radiographically fixed by bony ingrowth. Twenty-three well-fixed stems had to be removed for femoral head damage at the time of the acetabular revision. The results of this comparatively large series show that good fixation has been achieved with a proximal titanium mesh and grit-blasted titanium alloy stem.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067637     DOI: 10.1016/s0883-5403(03)00402-9

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Fifteen- to 20-year results of uncemented tapered fully porous-coated cobalt-chrome stems.

Authors:  Taek Rim Yoon; Sung-Man Rowe; Myung-Sun Kim; Sang-Gwon Cho; Jong-Keun Seon
Journal:  Int Orthop       Date:  2007-02-24       Impact factor: 3.075

2.  Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures.

Authors:  Wender Figved; Vidar Opland; Frede Frihagen; Tore Jervidalo; Jan Erik Madsen; Lars Nordsletten
Journal:  Clin Orthop Relat Res       Date:  2009-01-07       Impact factor: 4.176

3.  Behaviour of MG-63 osteoblast-like cells on wood-based biomorphic SiC ceramics coated with bioactive glass.

Authors:  A de Carlos; J P Borrajo; J Serra; P González; B León
Journal:  J Mater Sci Mater Med       Date:  2006-06       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.